Pre-Clinical Toxicity: Avoiding Common Mistakes in Early Development
Add bookmark
Dr. Mitchell Friedman, Director of Toxicology at Takeda Pharmaceuticals, discusses pre-clinical toxicity and avoiding common mistakes in early development so as to secure patient safety and better ROI. [inlinead]
